2023 ETF Series Trust - Brandes International ETF (BINV US) stock market data APIs
38.3547
-0.86(-2.2%)
as of October 14, 2025
Try our APIs with
free plan!
2023 ETF Series Trust - Brandes International ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
38.3547
Open
37.4902
High
38.0626
Low
37.8593
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 2023 ETF Series Trust - Brandes International ETF data using free add-ons & libraries
End-of-day & Earnings data
Get 2023 ETF Series Trust - Brandes International ETF Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get 2023 ETF Series Trust - Brandes International ETF End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
2023 ETF Series Trust - Brandes International ETF News
New
Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
Poster presentation on BT-001 in combination with pembrolizumab has shown tumor shrinkage in both injected and non-injected lesions Strasbourg, France, and Lund, Sweden, October 13, 2025, 8:30 a.m. ...
Transgene et BioInvent présentent des données translationnelles et la mise à jour des résultats cliniques du virus oncolytique armé BT-001 à l’ESMO 2025
La présentation d’un poster de BT-001 en combinaison avec pembrolizumab montre une réduction tumorale dans des lésions injectées et non injectées Strasbourg, France, et Lund, Suède, le 13 oct...
BioInvent Announces Initiation of BI-1206 Phase 2a Trial in Advanced or Metastatic NSCLC and Uveal Melanoma
LUND, SE / ACCESS Newswire / October 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) (STO:BINV), a biotech company focused on the discovery and development of novel and firs...
High Growth Tech Stocks To Watch In Europe July 2025
As Europe navigates a landscape marked by tentative optimism surrounding an EU-U.S. trade deal and the European Central Bank's steady interest rates, the pan-European STOXX Europe 600 Index has seen m...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
